Mitchell McLeod Pugh & Williams’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $687K | Buy |
8,779
+2,654
| +43% | +$214K | 0.08% | 179 |
|
|
2026
Q1 | $531K | Buy |
6,125
+82
| +1% | +$7.86K | 0.08% | 188 |
|
|
2025
Q4 | $622K | Buy |
6,043
+117
| +2% | +$11.4K | 0.09% | 176 |
|
|
2025
Q3 | $552K | Sell |
5,926
-20
| -0.3% | -$1.84K | 0.09% | 172 |
|
|
2025
Q2 | $518K | Hold |
5,946
| – | – | 0.1% | 177 |
|
|
2025
Q1 | $534K | Hold |
5,946
| – | – | 0.11% | 168 |
|
|
2024
Q4 | $475K | Sell |
5,946
-244
| -4% | -$21.1K | 0.1% | 180 |
|
|
2024
Q3 | $557K | Hold |
6,190
| – | – | 0.12% | 164 |
|
|
2024
Q2 | $487K | Sell |
6,190
-827
| -12% | -$67.8K | 0.11% | 163 |
|
|
2024
Q1 | $612K | Sell |
7,017
-60
| -0.8% | -$5.12K | 0.15% | 148 |
|
|
2023
Q4 | $583K | Sell |
7,077
-106
| -1% | -$8.08K | 0.15% | 145 |
|
|
2023
Q3 | $563K | Buy |
7,183
+387
| +6% | +$32.4K | 0.17% | 141 |
|
|
2023
Q2 | $599K | Buy |
6,796
+384
| +6% | +$33.1K | 0.17% | 133 |
|
|
2023
Q1 | $517K | Buy |
6,412
+95
| +2% | +$7.74K | 0.16% | 143 |
|
|
2022
Q4 | $491K | Buy |
6,317
+174
| +3% | +$14.1K | 0.17% | 144 |
|
|
2022
Q3 | $496K | Buy |
6,143
+398
| +7% | +$35.8K | 0.19% | 127 |
|
|
2022
Q2 | $516K | Sell |
5,745
-79
| -1% | -$8K | 0.2% | 126 |
|
|
2022
Q1 | $646K | Sell |
5,824
-452
| -7% | -$47.8K | 0.22% | 119 |
|
|
2021
Q4 | $649K | Buy |
6,276
+100
| +2% | +$11.6K | 0.21% | 121 |
|
|
2021
Q3 | $774K | Hold |
6,176
| – | – | 0.29% | 103 |
|
|
2021
Q2 | $767K | Sell |
6,176
-14
| -0.2% | -$1.76K | 0.3% | 105 |
|
|
2021
Q1 | $731K | Buy |
6,190
+157
| +3% | +$18.4K | 0.31% | 100 |
|
|
2020
Q4 | $707K | Hold |
6,033
| – | – | 0.32% | 97 |
|
|
2020
Q3 | $627K | Buy |
6,033
+415
| +7% | +$41.7K | 0.32% | 103 |
|
|
2020
Q2 | $515K | Hold |
5,618
| – | – | 0.29% | 109 |
|
|
2020
Q1 | $507K | Hold |
5,618
| – | – | 0.39% | 87 |
|
|
2019
Q4 | $637K | Hold |
5,618
| – | – | 0.4% | 85 |
|
|
2019
Q3 | $610K | Sell |
5,618
-866
| -13% | -$90.4K | 0.41% | 82 |
|
|
2019
Q2 | $631K | Buy |
6,484
+80
| +1% | +$7.3K | 0.43% | 83 |
|
|
2019
Q1 | $583K | Sell |
6,404
-1,100
| -15% | -$98.5K | 0.41% | 87 |
|
|
2018
Q4 | $683K | Sell |
7,504
-43
| -0.6% | -$4.02K | 0.55% | 64 |
|
|
2018
Q3 | $742K | Sell |
7,547
-1,607
| -18% | -$149K | 0.5% | 65 |
|
|
2018
Q2 | $784K | Sell |
9,154
-625
| -6% | -$52.2K | 0.55% | 60 |
|
|
2018
Q1 | $784K | Sell |
9,779
-1,100
| -10% | -$90.7K | 0.56% | 60 |
|
|
2017
Q4 | $878K | Hold |
10,879
| – | – | 0.61% | 57 |
|
|
2017
Q3 | $846K | Hold |
10,879
| – | – | 0.62% | 57 |
|
|
2017
Q2 | $966K | Hold |
10,879
| – | – | 0.73% | 44 |
|
|
2017
Q1 | $876K | Hold |
10,879
| – | – | 0.69% | 49 |
|
|
2016
Q4 | $775K | Sell |
10,879
-943
| -8% | -$74.1K | 0.63% | 58 |
|
|
2016
Q3 | $1.02M | Hold |
11,822
| – | – | 0.89% | 34 |
|
|
2016
Q2 | $1.03M | Sell |
11,822
-2,340
| -17% | -$189K | 0.93% | 32 |
|
|
2016
Q1 | $1.06M | Hold |
14,162
| – | – | 1.03% | 29 |
|
|
2015
Q4 | $1.09M | Hold |
14,162
| – | – | 1.08% | 26 |
|
|
2015
Q3 | $948K | Hold |
14,162
| – | – | 0.98% | 28 |
|
|
2015
Q2 | $1.05M | Hold |
14,162
| – | – | 0.97% | 29 |
|
|
2015
Q1 | $1.1M | Buy |
14,162
+262
| +2% | +$19.9K | 1.01% | 27 |
|
|
2014
Q4 | $1M | Buy |
+13,900
| New | +$966K | 0.93% | 32 |
|
Other funds holding MDT
Mitchell McLeod Pugh & Williams's MDT Position: Q2 2026 in Review
Mitchell McLeod Pugh & Williams increased its Medtronic (MDT) stake by 43% in Q2 2026, buying an estimated $214K and bringing the position to 8,779 shares worth $687K. The position accounts for 0.08% of the portfolio, ranked #179.
Mitchell McLeod Pugh & Williams first reported a position in MDT in Q4 2014 and has held it in 47 quarters since. The position peaked at $1.1M in Q1 2015. 2,128 funds tracked by Wall St. Rank hold MDT as of Q2 2026.
- Mitchell McLeod Pugh & Williams held 8,779 shares of Medtronic worth $687K as of Q2 2026.
- Mitchell McLeod Pugh & Williams bought 2,654 Medtronic shares in Q2 2026, an estimated $214K.
- Medtronic made up 0.08% of Mitchell McLeod Pugh & Williams's portfolio in Q2 2026, its #179 holding.
- Mitchell McLeod Pugh & Williams first reported a position in Medtronic in Q4 2014 and has held it in 47 quarters since.
- Mitchell McLeod Pugh & Williams's Medtronic position peaked at $1.1M in Q1 2015.
- 2,128 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.
Based on Mitchell McLeod Pugh & Williams's 13F filing for Q2 2026, filed 11 Aug 2026.